ReviewThe clinical respiratory journal2026
Primary Malignant Pulmonary Glomus Tumor: A Case Report and Literature Review.
Review in The clinical respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Malignant glomus tumors originating from the lungs are relatively rare. We report a case of primary malignant pulmonary glomus tumor in a 41-year-old female. Chest CT revealed an 8 × 6 cm mass in the upper lobe of the right lung with multiple spotted calcifications, with uneven enhancement on enhanced scans; multiple metastatic nodules can be seen in both lungs; enlarged lymph nodes can be seen in the mediastinum and right hilar lobe. The pathological diagnosis of right lung puncture was malignant pulmonary glomus tumor. Chemotherapy and targeted therapy with arotinib hydrochloride were used, and survival was still observed after 36 months of follow-up. The clinical manifestations of primary malignant pulmonary glomus tumor lack specificity. The imaging manifestations are well-defined nodules or masses, with peripheral enhancement on enhanced scans. The imaging manifestations of benign and malignant pulmonary glomus tumor overlap with other lung tumors, making differential diagnosis difficult. The diagnosis is mainly based on pathology and immunohistochemical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.